AbbVie | ABBV - Umsatzerlöse

Aktienkurs
206.11
Täglich Wechseln
-2.05 -0.98%
Monatlich
-0.28%
Jährlich
10.13%
Q2 Prognose
202.30




Der Umsatz Veränderung Datum
AbbVie USD 15B 1.62B 2026-03
Abbott USD 11.16B 300M 2026-03
ALKERMES USD 392.91M 8.41M 2026-03
Amgen USD 8.62B 1.28B 2026-03
AstraZeneca USD 15.29B 213M 2026-03
Biogen USD 2.25B 30M 2026-03
BioMarin Pharmaceutical USD 766M 109M 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Coherus Biosciences USD 12.75M 1.18M 2025-12
Eisai JPY 219.94B 22.58B 2025-12
Eli Lilly USD 19.8B 500M 2026-03
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 7.63B 991M 2026-03
Infinity Pharmaceuticals USD 583K 148K 2023-06
J&J USD 24.1B 500M 2026-03
Medtronic USD 9B 39M 2026-01
Merck USD 16.29B 110M 2026-03
Neurocrine Biosciences USD 811M 5.5M 2026-03
Novartis USD 13.11B 226M 2026-03
Pacira USD 177M 19.87M 2026-03
Perrigo USD 1.11B 70M 2025-12
Pfizer USD 14.5B 3.08B 2026-03
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
UCB EUR 4.25B 764M 2025-12
Ultragenyx Pharmaceutical USD 136M 71M 2026-03
United Therapeutics USD 790.2M 9.3M 2025-12
Vertex Pharmaceuticals USD 2.99B 200M 2026-03
Zoetis USD 2.4B 0 2025-12